What is the recommended dosing schedule for buspirone, including initial dose, titration increments, maximum daily dose, and adjustments for elderly or hepatic impairment?

Buspirone Dosing

Start buspirone at 5 mg twice daily and titrate by 5 mg every 2-3 days to a target of 15-30 mg daily in divided doses, with a maximum of 60 mg daily (20 mg three times daily). 1

Initial Dosing

• Standard starting dose: 5 mg twice daily 1, 2
• The medication is rapidly absorbed but undergoes extensive first-pass metabolism, with peak plasma levels occurring 40-90 minutes after administration 2
• Food increases bioavailability significantly (84% increase in AUC, 116% increase in Cmax), so consider consistent timing with or without food 2

Titration Schedule

• Increase by 5 mg increments every 2-3 days as tolerated to reach therapeutic effect 1
• Target maintenance dose: 15-30 mg daily in divided doses (either twice or three times daily) 1, 3
• Both BID and TID regimens at 30 mg/day show equivalent efficacy and safety profiles 3
• Maximum dose: 60 mg daily (20 mg three times daily) 1

Time to Therapeutic Effect

• Allow 2-4 weeks for clinical effect to become apparent 1
• The elimination half-life is only 2-3 hours, but therapeutic anxiolytic effects develop gradually 2, 4
• Steady-state is reached after 3-5 days of dosing 5

Special Population Adjustments

Elderly Patients

• No routine dose adjustment required based solely on age 6
• Pharmacokinetics (AUC, Cmax) do not differ significantly between elderly and younger patients 2, 6
• Standard dosing of 15-30 mg/day (mean 18 mg/day) is effective and well-tolerated in elderly patients 7
• However, use clinical judgment and monitor closely as elderly patients may be more sensitive to CNS effects 2

Hepatic Impairment

• Severe dose reduction required: steady-state AUC increases 13-fold compared to healthy subjects 2
• Start with lower doses (e.g., 2.5 mg twice daily) and titrate cautiously 5
• The elimination half-life doubles in hepatic impairment 4, 5

Renal Impairment

• Moderate dose reduction recommended: steady-state AUC increases 4-fold in patients with creatinine clearance 10-70 mL/min/1.73 m² 2
• Start with lower doses and monitor closely 5
• Cmax and AUC approximately double after single doses in renal impairment 4, 5

Critical Drug Interactions Requiring Dose Adjustment

Strong CYP3A4 Inhibitors (Require Major Dose Reduction)

• Itraconazole: reduces buspirone to 2.5 mg once daily (19-fold increase in AUC) 2
• Nefazodone: reduces buspirone to 2.5 mg once daily (up to 50-fold increase in AUC) 2
• Erythromycin: reduces buspirone to 2.5 mg twice daily (6-fold increase in AUC) 2
• Diltiazem/Verapamil: significant dose reduction needed (4-5.5 fold increase in AUC) 2
• Grapefruit juice: avoid large amounts (9.2-fold increase in AUC) 2

CYP3A4 Inducers (May Require Dose Increase)

• Rifampin: may need dose adjustment to maintain effect (90% decrease in AUC) 2, 4
• Other inducers (phenytoin, phenobarbital, carbamazepine) may similarly increase buspirone metabolism 2

Common Pitfalls

• Do not expect immediate anxiolytic effect: Unlike benzodiazepines, buspirone requires 2-4 weeks for therapeutic benefit 1
• Nonlinear pharmacokinetics: Dose increases and repeated dosing lead to higher blood levels than predicted from single-dose studies 2
• Food effects are substantial: Counsel patients on consistent administration timing relative to meals 2
• Not interchangeable with benzodiazepines: Buspirone will not prevent benzodiazepine withdrawal and has no cross-tolerance 1
• Monitor for serotonin syndrome: Particularly when combined with other serotonergic agents 8